Federal regulators have warned more than 350 medical practices that Botox they may have received from a Canadian supplier is unapproved and could be counterfeit or unsafe.
The Food and Drug Administration said in a letter to the medical practices — nearly 20 of which are in the Los Angeles area — that batches of the wrinkle treatment shipped by suppliers owned by pharmacy Canada Drugs have not been approved by the FDA and that the agency cannot assure their effectiveness or their safety.
The FDA said Canada Drugs was previously tied to shipping unapproved and counterfeit cancer drugs.
The agency warned doctors about buying drugs from sources other than licensed U.S. pharmacies. It's the fifth warning the agency has made this year about foreign suppliers providing unapproved drugs.
In February, the agency warned 19 medical practices that they had received a counterfeit version of the cancer drug Avastin. On three more occasions the FDA issued similar warnings about counterfeit Avastin and Altuzan, another brand name for the same drug. The alerts were also primarily targeted at drugs distributed by Canada Drugs.
A request for comment from the drug distributor was not immediately returned.
Drug shortages have increased the financial incentives for some pharmacies to provide counterfeit or illegally imported drugs. The drugs subject to warnings have all been injectable treatments typically distributed through medical practices and not directly to patients.
In October, the FDA ordered operators of about 4,100 websites to immediately stop selling unapproved medications to U.S. consumers. The vast majority of those sites were operated by Canada Drugs.
Genuine Botox is made by Allergan Inc. in Irvine. Avastin is made by Swiss drug giant Roche Holding's Genentech unit in South San Francisco.
A link to the list of medical practices who were sent the letter can be found on the FDA website at http://1.usa.gov/R7jKiR.
FDA warns medical practices about Botox from Canadian supplier
This article
FDA warns medical practices about Botox from Canadian supplier
can be opened in url
http://theclubenews.blogspot.com/2012/12/fda-warns-medical-practices-about-botox.html?m=0
FDA warns medical practices about Botox from Canadian supplier
